| Isotretinoin | Approved Investigational | CALD1 | 800 |
upregulated | Isotretinoin results in increased expression of CALD1 mRNA | 7q33 | |
| Isotretinoin | Approved Investigational | CALML3 | 810 |
downregulated | Isotretinoin results in decreased expression of CALML3 mRNA | 10p15.1 | |
| Isotretinoin | Approved Investigational | CBX3 | 11335 |
downregulated | Isotretinoin results in decreased expression of CBX3 mRNA | 7p15.2 | |
| Isotretinoin | Approved Investigational | CCDC86 | 79080 |
downregulated | Isotretinoin results in decreased expression of CCDC86 mRNA | 11q12.2 | |
| Isotretinoin | Approved Investigational | CCL5 | 6352 |
downregulated | Isotretinoin results in decreased expression of CCL5 mRNA | 17q12 | |
| Isotretinoin | Approved Investigational | CD2 | 914 |
upregulated | Isotretinoin results in increased expression of CD2 mRNA | 1p13.1 | |
| Isotretinoin | Approved Investigational | CD34 | 947 |
upregulated | Isotretinoin results in increased expression of CD34 mRNA | 1q32.2 | |
| Isotretinoin | Approved Investigational | CD37 | 951 |
upregulated | Isotretinoin results in increased expression of CD37 mRNA | 19q13.33 | |
| Isotretinoin | Approved Investigational | CD3D | 915 |
upregulated | Isotretinoin results in increased expression of CD3D mRNA | 11q23.3 | |
| Isotretinoin | Approved Investigational | CD52 | 1043 |
upregulated | Isotretinoin results in increased expression of CD52 mRNA | 1p36.11 | |
| Isotretinoin | Approved Investigational | CD81 | 975 |
upregulated | Isotretinoin results in increased expression of CD81 mRNA | 11p15.5 | |
| Isotretinoin | Approved Investigational | CDA | 978 |
downregulated | Isotretinoin results in decreased expression of CDA mRNA | 1p36.12 | |
| Isotretinoin | Approved Investigational | CDC14B | 8555 |
upregulated | Isotretinoin results in increased expression of CDC14B mRNA | 9q22.32-q22.33 | |
| Isotretinoin | Approved Investigational | CDH5 | 1003 |
upregulated | Isotretinoin results in increased expression of CDH5 mRNA | 16q21 | |
| Isotretinoin | Approved Investigational | CDK5 | 1020 |
downregulated | Isotretinoin results in decreased expression of CDK5 mRNA | 7q36.1 | |
| Isotretinoin | Approved Investigational | CDK5RAP1 | 51654 |
downregulated | Isotretinoin results in decreased expression of CDK5RAP1 mRNA | 20q11.21 | |
| Isotretinoin | Approved Investigational | CDKN1A | 1026 |
downregulated | Isotretinoin results in decreased expression of CDKN1A mRNA | 6p21.2 | |
| Isotretinoin | Approved Investigational | CDKN1C | 1028 |
downregulated | Isotretinoin results in decreased expression of CDKN1C mRNA | 11p15.4 | |
| Isotretinoin | Approved Investigational | CEACAM1 | 634 |
downregulated | Isotretinoin results in decreased expression of CEACAM1 mRNA | 19q13.2 | |
| Isotretinoin | Approved Investigational | CEL | 1056 |
upregulated | Isotretinoin results in increased expression of CEL mRNA | 9q34.13 | |
| Isotretinoin | Approved Investigational | CELF2 | 10659 |
upregulated | Isotretinoin results in increased expression of CELF2 mRNA | 10p14 | |
| Isotretinoin | Approved Investigational | CERS4 | 79603 |
downregulated | Isotretinoin results in decreased expression of CERS4 mRNA | 19p13.2 | |
| Isotretinoin | Approved Investigational | CFAP45 | 25790 |
downregulated | Isotretinoin results in decreased expression of CFAP45 mRNA | 1q23.2 | |
| Isotretinoin | Approved Investigational | CHI3L1 | 1116 |
downregulated | Isotretinoin results in decreased expression of CHI3L1 mRNA | 1q32.1 | |
| Isotretinoin | Approved Investigational | CHI3L2 | 1117 |
downregulated | Isotretinoin results in decreased expression of CHI3L2 mRNA | 1p13.2 | |